Neural Oscillations as Genetic and Functional Biomarkers in Normal and Disease States
NCT01425671 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 800
Last updated 2024-04-26
Summary
The principle aim of the project is to analyze brain electrical activity and genetic information that will help identify the nature and cause of the disease schizophrenia. This effort should lay the groundwork for future treatment in schizophrenic patients.
Conditions
- Schizophrenia
- Schizoaffective Disorder
- Schizophreniform Disorder
Sponsors & Collaborators
-
National Institute of Mental Health (NIMH)
collaborator NIH -
University of Maryland, Baltimore
lead OTHER
Principal Investigators
-
L.Elliot Hong, M.D. · Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine
Eligibility
- Min Age
- 14 Years
- Max Age
- 62 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-11-30
- Primary Completion
- 2023-08-31
- Completion
- 2024-01-31
Countries
- United States
Study Locations
More Related Trials
-
Genetics of Symptomatology and Treatment Response in Psychotic Major Depression
NCT00691535 ·Status: COMPLETED
-
Translational Investigation of the Glutamatergic and GABAergic System in Schizophrenia
NCT04655235 ·Status: RECRUITING
-
Biomarker Strategies for Medication-Enhanced Cognitive Training in Schizophrenia
NCT01555697 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Brain Functions Underlying Visuospatial Attention Deficits in Schizophrenia
NCT01399437 ·Status: COMPLETED
-
Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors
NCT00178932 ·Status: COMPLETED ·Phase: NA
-
Brain Circuits in Schizophrenia and Smoking
NCT01425684 ·Status: COMPLETED
-
A Neurobiological Study on Heterogeneity of Schizophrenia: Genetic Variations and Neurobiological Differentiations
NCT01075373 ·Status: UNKNOWN
-
Neuropsychiatric Evaluation of Healthy Volunteers and Adults With Schizophrenia
NCT00001323 ·Status: COMPLETED
-
Neurobiological Effects of Oxytocin in Schizophrenia - Imaging Study
NCT04158167 ·Status: COMPLETED ·Phase: NA
-
Serotonin 1A Agonists and Cognition in Schizophrenia
NCT00178971 ·Status: COMPLETED ·Phase: PHASE3
-
Transcranial Direct and Alternating Stimulation of the Prefrontal Cortex for Cognitive Improvement in Schizophrenia
NCT05342727 ·Status: COMPLETED ·Phase: PHASE1
-
Visual Perception in Schizophrenia
NCT06911931 ·Status: RECRUITING ·Phase: NA
-
Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography
NCT00942981 ·Status: COMPLETED
-
Studies of Frontal Lobe Brain Functioning in Schizophrenia
NCT00001258 ·Status: COMPLETED
-
Effect of MMFS-202-302 on Cognitive Enhancement in Schizophrenia
NCT02237235 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Utility of Pharmacogenomics of Psychotropic Medications
NCT03907124 ·Status: WITHDRAWN ·Phase: PHASE4
-
Emotion Endophenotypes in Schizophrenia
NCT02834208 ·Status: UNKNOWN ·Phase: NA
-
Neuroplasticity in TBI and Schizophrenia
NCT03995368 ·Status: COMPLETED ·Phase: NA
-
Prebiotic Treatment in People With Schizophrenia
NCT05527210 ·Status: RECRUITING ·Phase: NA
-
Imaging of Brain Receptors in Healthy Volunteers and in Patients With Schizophrenia
NCT00061789 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment Response in Schizophrenia: Bridging Imaging and Postmortem Studies
NCT00937716 ·Status: COMPLETED
-
Schizophrenia Imaging
NCT01655472 ·Status: UNKNOWN ·Phase: NA
-
Psychiatric Multi-omics and Neuroimaging Project
NCT06580860 ·Status: RECRUITING
-
Parallel Effects of Schizophrenia and N-methyl-D-aspartate (NMDA) Antagonism
NCT02675530 ·Status: COMPLETED ·Phase: PHASE1
-
Novel Candidate Genes for Treatment Response to Antipsychotics in Schizophrenia
NCT02205437 ·Status: UNKNOWN